Hemodialysis: The participants receive hemodialysis for 4 hours, 3 times per week
Intradialytic resistive exercise: The participants will receive intradialytic resistive exercise for 12 weeks (3 sessions/ week).
Duration: 30 minutes during the first 2 hours of each dialysis session in a recumbent position or seated position.
Time of session: The program starts with a warm-up phase which is 3:5 minutes in the form of light aerobic and stretching exercises for big muscles and ends with a cooling down phase which is 3:5 in the form of light aerobic exercise.
The resistance exercises include exercises for the big muscles of only the Lower Limbs (LL) muscles of single and multiple-joint which are:1- Knee extensors, 2- Knee flexors, 3- Hip flexors, 4- Hip abductors and adductors. using sandbags of different weights. Sandbag weights are placed on the distal third of the tibia for LL exercises.
Intensity: On the Borg's Scale of Perceived Exertion, which will be measured every 5 minutes during exercise.
Intradialytic aerobic exercise: Patients with chronic kidney disease will receive an intradialytic aerobic exercise for 12 weeks (3 sessions/ week).
Duration: 30 minutes during the first 2 hours of each dialysis session using a stationary bicycle ergometer in a supine position or seated position.
Time of session: The warming up and the cooling down phase consists of 5:10 minutes of slow Pedaling. the main exercise phase consisted of 20 minutes of cycling.
Intensity: The use of the Borg's Scale of Perceived Exertion (RPE) scale enables the intensity of the exercise to be adapted According to the tolerance of each patient.
The use of the RPE scale enables the intensity of the exercise to be adapted According to the tolerance of each patient, the aim was to obtain between 11 light And 14 somewhat hard.
Study summary
The purpose of the study is to compare the effect of resistance exercise and aerobic exercise on intradialytic hypotension in patients undergoing hemodialysis.
Eligibility
Sex
FEMALE
Min age
45 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* End-stage renal disease (ESRD) or stage 5 chronic kidney disease (CKD) in which on maintenance regular HD (three sessions/week (on alternate days), for four hours/session for more than a year to five years when starting the study.
* Both gender male and female aged from 45 to 60 years old.
* Patients with intradialytic hypotension sudden drops of systolic pressure of more than 20 mm Hg or diastolic pressure of more than 10 mmHg.
* Receiving hemodialysis (HD) through uncomplicated arm arteriovenous (A-V) fistula.
* Patients with Body Mass Index (BMI): 18,5 \< 30kg/m2.
* In a stable medical, clinical, and hemodynamic condition
* Untrained at baseline and did not participate in any regular physical activity before.
Exclusion Criteria:
* Severe Chest diseases (either obstructive or restrictive).
* Clinical signs of a severe cardiac event. (eg, severe atherosclerosis, congestive heart failure),
* Severe psychiatric or cognitive impairment, who unable to follow comment.
* Neurological disorders affecting respiratory muscles or any muscular dystrophies (cervical disc or bulge).
* Patients with severe self-limiting illness (e.g., cancer).
* Patients with Body Mass Index (BMI) \> 30kg/m2.
* Previous renal transplantation patients.
* Pregnant females or became pregnant during the study.
* Patients started HD in less than a year or more than 5 years.
* Hospitalized during the prior month.
* Patients who were irregular in HD or not adherent to the exercise program.
Primary outcome measure(s)
Systolic blood pressure measurement — 12 weeks Blood pressure (BP) will be measured on the non-access arm using automatic BP cuffs attached to the patient's hemodialysis machine which is used routinely at each respective hemodialysis clinic. As well as for ankle brachial pressure index. Systolic blood pressure measurements will be taken pre-hemodialysis, at hemodialysis start (baseline), post-hemodialysis, and every 15 minutes during each dialysis session. BP measurements will be taken before selected exercise and after exercise.
Diastolic blood pressure measurement — 12 weeks Blood pressure (BP) will be measured on the non-access arm using automatic BP cuffs attached to the patient's hemodialysis machine which is used routinely at each respective hemodialysis clinic. As well as for ankle brachial pressure index. diastolic blood pressure measurements will be taken pre-hemodialysis, at hemodialysis start (baseline), post-hemodialysis, and every 15 minutes during each dialysis session. BP measurements will be taken before selected exercise and after exercise.
Ankle-Brachial Index (ABI) — 12 weeks This non-invasive test compares blood pressure in the ankles to blood pressure in the arms. An ABI below 0.9 usually suggests peripheral artery disease (PAD), a common cause of circulatory issues.
Peripheral oxygen saturation — 12 weeks Pulse oximetry is a non-invasive method used to measure the oxygen saturation level (SpO2) in the blood, providing an estimate of how much oxygen the hemoglobin in red blood cells is carrying. It provides data on oxygen delivery to extremities, which may be impaired in circulation issues. Normally, its value is 95-99%.
Creatinine level — 12 weeks Blood analysis will be used to measure creatinine level for all patients before and after intervention. Its values vary by sex; 0.6-1.2 mg/dl for men and 0.5-1.1 mg/dl for women.
blood urea level — 12 weeks Blood analysis will be used to measure blood urea for all patients before and after intervention. its normal value ranges from 17-43 mg/dl.
blood urea nitrogen test — 12 weeks Blood analysis will be used to measure blood urea nitrogen for all patients before and after intervention. its normal value ranges from 7-20 mg/dl.
serum albumin — 12 weeks Blood analysis will be used to measure serum albumin for all patients before and after intervention. its normal value in adults is typically 3.5-5.0 g/L.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.